Analyst Confidence Soars as Addus HomeCare Receives Multiple Price Target Upgrades
Published on 09/11/2025 at 12:18 | Redaktion boerse-global.deMarket analysts are expressing strong bullish sentiment toward Addus HomeCare, with ten separate firms now recommending the stock as a buy opportunity. The consensus view suggests substantial upside potential, with average price targets indicating more than 20 percent growth from current trading levels.
Several major financial institutions have recently updated their assessments of Addus HomeCare’s stock value:
- Stephens maintained its Overweight rating with a $140 target (September 3)
- RBC Capital Markets raised its target from $133 to $134 while keeping an Outperform rating (August 22)
- TD Cowen increased its target from $135 to $139, reiterating a Strong Buy recommendation (August 6)
- Barclays significantly adjusted its target upward from $83 to $109, despite maintaining... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
